News : WNS Extends Contract with GSK to Provide High-end Analytical Services
New York & Mumbai, India March, 2016-- WNS (Holdings) Limited (NYSE: WNS), a provider of global Business Process Management (BPM) services, announced that it has extended its service contract with global pharmaceutical provider GlaxoSmithKline (GSK) until December, 2020.
"We are extremely proud to renew our agreement with GSK. For more than a decade, WNS has been a trusted partner driving evidence-based decisions through high-end research and analytics services. Under the agreement with GSK, WNS has set up a dedicated state-of-the-art Knowledge Center, driven by a team of over 600 industry experts. WNS leverages its deep Pharma domain knowledge, robust analytics capabilities and proprietary frameworks to deliver actionable business insights to GSK," said Keshav R. Murugesh, Group CEO, WNS.
Posted by: Laura Collins, Editorial Management
Today's Tip of the Day - Information
More Editorial From WNS Global Services
About WNS Global Services:
WNS Global Services is a large global Business Process Outsourcing company headquartered in Mumbai, India. WNS formerly stood for World Network Services.
We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare.
Published: Friday, March 11, 2016